The ultimate utility of the serum prostate specific antigen (PSA) assay as a screening test for
reducing prostate cancer mortality has been an area of intense controversy since its …

Objective According to several guidelines, it is acceptable to spare a bone scan in the
patients who are newly diagnosed with low-risk prostate cancer. Our aim is to clarify a …

Abstract Context Prostate cancer (PCa) is the most common malignancy in men in
westernized cultures and the incidence of PCa is rapidly rising in low-risk countries due to …

Introduction Data regarding prostate cancer screening in Brazil are limited. We compared
features of prostate cancers detected through screening versus those referred for treatment …

Similar to other common malignancies such as breast and cervical cancers, the issue of
population screening with prostate-specific antigen (PSA) appears enticing, and the …

With the recent publication of two randomized prostate cancer (PCa) screening trials, the
ongoing discussion of whether prostate-specific antigen (PSA)–based screening for PCa …

Results We observed a higher knowledge about carcinoma of prostate in group A than in
group B (p< 0.0001) and it increased after 5 years in group D (p< 0.0001) in comparison to …

Lai gan 5 gadu dzīvildzes rādītāji turpina uzlaboties, prostatas vēzis joprojām ir nopietna
veselības problēma. Prostatas vēţa izpausmes mainās. Mūsdienās atrastie audzēji ir …

Prostate cancer is the most commonly diagnosed cancer among men in the United States. It
is frequently cited that racial disparities in mortality between Caucasian and African …

Introdução: O carcinoma da próstata é a segunda causa de morte por cancro na Europa. O
diagnóstico exige biópsia prostática, sendo a sua realização condicionada por preditores …